Back

Digitoxin and digoxin: standard therapy for HFrEF?

9 May 2026 (08:30 - 08:45)
Organised by: Logo
Congress Presentation Part of: Controversies in contemporary drug therapy for heart failure Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Verigicuat: standard therapy for HFrEF?
Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
Doctor A. Ruwald (Copenhagen, DK)
Slides Video
Presentation thumbnail
Controversies in contemporary drug therapy for heart failure - discussion
Video

Access the full session

Session thumbnail
Controversies in contemporary drug therapy for heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Discussant review - DECISION/DIGIT-HF/DIG Meta Analysis
10 May 2026
thumbnail
Congress Presentation
'Inotropes' for the treatment of heart failure remain dead and buried! – the final word.
27 August 2022
thumbnail
Congress Presentation
The role of digoxin in atrial fibrillation.
5 April 2022
thumbnail
Congress Session
Late breaking clinical trials: medical therapy
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources